New hope for wet AMD: could a common antibiotic clear stubborn eye fluid?
NCT ID NCT04504123
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tests whether an oral antibiotic (doxycycline) can help people with wet age-related macular degeneration (AMD) who still have fluid in the eye despite standard injections. About 50 participants will receive either doxycycline or a placebo for up to 12 months. The goal is to see if the pill can clear the fluid and reduce the need for eye injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa Hospitals & Clinics Department of Ophthalmology & Visual Sciences
RECRUITINGIowa City, Iowa, 52242, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.